Vascular endothelial growth factor: basic science and clinical progress

N Ferrara - Endocrine reviews, 2004 - academic.oup.com
Vascular endothelial growth factor (VEGF) is an endothelial cell-specific mitogen in vitro and
an angiogenic inducer in a variety of in vivo models. Hypoxia has been shown to be a major …

Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

N Ferrara, KJ Hillan, HP Gerber… - Nature reviews Drug …, 2004 - nature.com
The existence of factors that stimulate blood vessel growth, thereby recruiting a neovascular
supply to nourish a growing tumour, was postulated many decades ago, although the …

Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy

N Ferrara, KJ Hillan, W Novotny - Biochemical and biophysical research …, 2005 - Elsevier
Vascular endothelial growth factor (VEGF) is an endothelial cell-specific mitogen in vitro and
an angiogenic inducer in vivo. The tyrosine kinases Flt-1 (VEGFR-1) and Flk-1/KDR (VEGFR …

Angiogenesis and its therapeutic opportunities

SY Yoo, SM Kwon - Mediators of inflammation, 2013 - Wiley Online Library
Angiogenesis plays critical roles in human physiology that range from reproduction and fetal
growth to wound healing and tissue repair. The sophisticated multistep process is tightly …

[HTML][HTML] Role of vascular endothelial growth factor in the regulation of angiogenesis

N Ferrara - Kidney international, 1999 - Elsevier
Role of vascular endothelial growth factor in the regulation of angiogenesis. Compelling
evidence indicates that vascular endothelial growth factor (VEGF) is a fundamental regulator …

VEGF165b, an Inhibitory Splice Variant of Vascular Endothelial Growth Factor, Is Down-Regulated in Renal Cell Carcinoma

DO Bates, TG Cui, JM Doughty, M Winkler, M Sugiono… - Cancer research, 2002 - AACR
Angiogenesis is essential for tumor growth. Vascular endothelial growth factor (VEGF) is the
most potent growth factor of tumor neovasculature, has been shown to be up-regulated in …

VEGF165b, an Inhibitory Vascular Endothelial Growth Factor Splice Variant: Mechanism of Action, In vivo Effect On Angiogenesis and Endogenous Protein …

J Woolard, WY Wang, HS Bevan, Y Qiu, L Morbidelli… - Cancer research, 2004 - AACR
Growth of new blood vessels (angiogenesis), required for all tumor growth, is stimulated by
the expression of vascular endothelial growth factor (VEGF). VEGF is up-regulated in all …

VHL and HIF signalling in renal cell carcinogenesis

MM Baldewijns, IJH van Vlodrop… - The Journal of …, 2010 - Wiley Online Library
Hypoxia‐inducible factor (HIF) plays an important role in renal tumourigenesis. In the
majority of clear cell RCC (ccRCC), the most frequent and highly vascularized RCC subtype …

Biology and clinical development of vascular endothelial growth factor–targeted therapy in renal cell carcinoma

BI Rini, EJ Small - Journal of Clinical Oncology, 2005 - ascopubs.org
Purpose To review the biology of renal cell carcinoma (RCC) leading to vascular endothelial
growth factor (VEGF) overexpression and the clinical results of VEGF blockade in metastatic …

Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood

RM Bremnes, C Camps, R Sirera - Lung cancer, 2006 - Elsevier
BACKGROUND: Due to a dismal prognosis of advanced lung cancer, novel screening tools
and more effective treatments are clearly needed. Lately, an increasing number of tumour …